— Know what they know.
Not Investment Advice

BCPC NASDAQ

Balchem Corp
1W: -1.7% 1M: +0.0% 3M: +3.0% YTD: +9.5% 1Y: +8.3% 3Y: +40.1% 5Y: +13.1%
$168.70
-1.92 (-1.13%)
 
Weekly Expected Move ±2.1%
$170 $173 $177 $181 $184
NASDAQ · Basic Materials · Chemicals - Specialty · Tech Score Buy · Power 71 · $5.4B mcap · 32M float · 0.755% daily turnover · Short 55% of daily vol
Credit Risk of going bust: lower than 96% of companies Debt: 2.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.21 (down 99.9%), Balchem Corp would be worth roughly what it owes.
Total debt $142.4M against a stock market value of $5.38B.
Distance to default 21.66 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $66.0M (short-term plus half of long-term), stock volatility 20.7%; Altman Z 10.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-06-15
Earliest Filing
2022-06-15
Latest Filing
target: 3

Counterparties (Filed by BCPC)

3 relationships

Companies named in BCPC's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Kechu MidCo AS — target Seller of Kechu BidCo AS and its subsidiary companies in the acquisition transaction. 2022-06-15 View
Kechu BidCo AS — target Target company being acquired by Balchem Corporation and its subsidiary. 2022-06-15 View
Kappa Bioscience AS — target Leading manufacturer of specialty Vitamin K2 and a subsidiary of Kechu BidCo AS being acquired. 2022-06-15 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-23 Earnings Release; Exhibits View
2026-07-31 Earnings Release; Exhibits View
2026-07-27 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-06-22 Shareholder Vote View
2026-04-30 Earnings Release; Exhibits View
2026-02-20 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-02-19 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-12-10 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-10-21 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-31 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-20 Submission of Matters to a Vote of Security Holders View
2025-04-24 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-03 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-02-21 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-02-14 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2024-12-10 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-10-25 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-17 Departure/Election of Directors; Appointment of Officers View
2024-09-20 Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or View
2024-06-24 Submission of Matters to a Vote of Security Holders View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms